Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.

Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, Shulman DG.

J Clin Laser Med Surg. 1996 Apr;14(2):59-66. Review.

PMID:
9484077
2.
3.

5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.

Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM.

Cancer. 1997 Jun 15;79(12):2282-308. Review.

PMID:
9191516
4.
5.

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.

Kennedy JC, Pottier RH.

J Photochem Photobiol B. 1992 Jul 30;14(4):275-92. Review.

PMID:
1403373
6.

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, Langmack K, McKenna K, Moseley H, Pearse AD, Stringer M, Taylor DK, Wong G, Rhodes LE.

Br J Dermatol. 2002 Apr;146(4):552-67. Review.

PMID:
11966684
7.

Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.

Tan WC, Fulljames C, Stone N, Dix AJ, Shepherd N, Roberts DJ, Brown SB, Krasner N, Barr H.

J Photochem Photobiol B. 1999 Nov-Dec;53(1-3):75-80.

PMID:
10672532
8.

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.

Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA.

J Eur Acad Dermatol Venereol. 2001 Nov;15(6):550-4.

PMID:
11843215
11.

Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.

Boere IA, Robinson DJ, de Bruijn HS, Kluin J, Tilanus HW, Sterenborg HJ, de Bruin RW.

Photochem Photobiol. 2006 Nov-Dec;82(6):1638-44.

PMID:
16879035
12.

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

Kennedy JC, Pottier RH, Pross DC.

J Photochem Photobiol B. 1990 Jun;6(1-2):143-8.

PMID:
2121931
13.

The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis.

Kelty CJ, Brown NJ, Reed MW, Ackroyd R.

Photochem Photobiol Sci. 2002 Mar;1(3):158-68. Review.

PMID:
12659511
14.

5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.

Ackroyd R, Brown N, Vernon D, Roberts D, Stephenson T, Marcus S, Stoddard C, Reed M.

Photochem Photobiol. 1999 Oct;70(4):656-62.

PMID:
10546561
15.

Photodynamic therapy of Walker tumors by multiple laser irradiation.

Calin MA, Gruia MI, Herascu N, Coman T.

Photomed Laser Surg. 2005 Aug;23(4):405-9.

PMID:
16144485
16.

Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo.

Juzeniene A, Juzenas P, Moan J.

Methods Mol Biol. 2010;635:97-106. doi: 10.1007/978-1-60761-697-9_7.

PMID:
20552342
17.

Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.

de Souza AL, Marra K, Gunn J, Samkoe KS, Kanick SC, Davis SC, Chapman MS, Maytin EV, Hasan T, Pogue BW.

Br J Cancer. 2016 Sep 27;115(7):805-13. doi: 10.1038/bjc.2016.267. Epub 2016 Aug 30.

19.

Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.

Martin A, Tope WD, Grevelink JM, Starr JC, Fewkes JL, Flotte TJ, Deutsch TF, Anderson RR.

Arch Dermatol Res. 1995;287(7):665-74.

PMID:
8534131

Supplemental Content

Support Center